Bluejay Diagnostics (BJDX) Operating Expenses (2020 - 2026)

Bluejay Diagnostics' Operating Expenses history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 2.64% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $7.0 million (up 5.62% YoY), while the FY2025 annual figure was $7.0 million, down 3.02% from the prior year.
• Operating Expenses came in at $1.9 million for Q1 2026 at Bluejay Diagnostics, up from $1.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.8 million in Q3 2022 to a low of $336.0 in Q2 2023.
• A 5-year average of $1.9 million and a median of $2.0 million in 2025 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses slumped 99.98% in 2023 and soared 563965.77% in 2024, its largest moves.
• Bluejay Diagnostics' Operating Expenses stood at $2.5 million in 2022, then decreased by 2.73% to $2.4 million in 2023, then sank by 37.8% to $1.5 million in 2024, then decreased by 1.54% to $1.5 million in 2025, then jumped by 32.64% to $1.9 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $1.9 million, $1.5 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison